Flora Growth (FLGC) Competitors $0.54 +0.05 (+11.26%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.52 -0.02 (-3.06%) As of 04/17/2025 05:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FLGC vs. RNTX, PEPG, XFOR, KPTI, HOWL, NRXP, ATRA, ESLA, COEP, and KZRShould you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Rein Therapeutics (RNTX), PepGen (PEPG), X4 Pharmaceuticals (XFOR), Karyopharm Therapeutics (KPTI), Werewolf Therapeutics (HOWL), NRx Pharmaceuticals (NRXP), Atara Biotherapeutics (ATRA), Estrella Immunopharma (ESLA), Coeptis Therapeutics (COEP), and Kezar Life Sciences (KZR). These companies are all part of the "pharmaceutical products" industry. Flora Growth vs. Rein Therapeutics PepGen X4 Pharmaceuticals Karyopharm Therapeutics Werewolf Therapeutics NRx Pharmaceuticals Atara Biotherapeutics Estrella Immunopharma Coeptis Therapeutics Kezar Life Sciences Flora Growth (NASDAQ:FLGC) and Rein Therapeutics (NASDAQ:RNTX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations and profitability. Which has higher earnings and valuation, FLGC or RNTX? Rein Therapeutics has lower revenue, but higher earnings than Flora Growth. Rein Therapeutics is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFlora Growth$59.51M0.18-$57.04M-$1.32-0.41Rein TherapeuticsN/AN/A-$15.73M-$3.47-0.49 Do analysts rate FLGC or RNTX? Flora Growth presently has a consensus target price of $5.00, suggesting a potential upside of 828.51%. Given Flora Growth's stronger consensus rating and higher possible upside, analysts plainly believe Flora Growth is more favorable than Rein Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Rein Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is FLGC or RNTX more profitable? Rein Therapeutics has a net margin of 0.00% compared to Flora Growth's net margin of -30.99%. Rein Therapeutics' return on equity of -74.08% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets Flora Growth-30.99% -268.17% -57.51% Rein Therapeutics N/A -74.08%-27.93% Does the MarketBeat Community believe in FLGC or RNTX? Flora Growth received 15 more outperform votes than Rein Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformFlora GrowthOutperform Votes1560.00% Underperform Votes1040.00% Rein TherapeuticsN/AN/A Do insiders and institutionals have more ownership in FLGC or RNTX? 36.0% of Flora Growth shares are owned by institutional investors. Comparatively, 90.9% of Rein Therapeutics shares are owned by institutional investors. 13.0% of Flora Growth shares are owned by insiders. Comparatively, 5.1% of Rein Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media prefer FLGC or RNTX? In the previous week, Rein Therapeutics had 3 more articles in the media than Flora Growth. MarketBeat recorded 3 mentions for Rein Therapeutics and 0 mentions for Flora Growth. Rein Therapeutics' average media sentiment score of 0.53 beat Flora Growth's score of 0.00 indicating that Rein Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Flora Growth Neutral Rein Therapeutics Positive Which has more volatility and risk, FLGC or RNTX? Flora Growth has a beta of 2.01, suggesting that its share price is 101% more volatile than the S&P 500. Comparatively, Rein Therapeutics has a beta of 2.12, suggesting that its share price is 112% more volatile than the S&P 500. SummaryFlora Growth and Rein Therapeutics tied by winning 8 of the 16 factors compared between the two stocks. Get Flora Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGC vs. The Competition Export to ExcelMetricFlora GrowthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.47M$6.46B$5.32B$7.35BDividend YieldN/A3.21%5.47%4.31%P/E Ratio-0.416.9521.9417.82Price / Sales0.18231.01380.9497.72Price / CashN/A65.6738.3134.64Price / Book0.695.936.453.98Net Income-$57.04M$143.22M$3.22B$247.81M7 Day Performance17.07%4.28%5.85%3.19%1 Month Performance-18.07%-13.11%-9.58%-7.70%1 Year Performance-65.48%-8.51%11.85%1.49% Flora Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGCFlora Growth1.9561 of 5 stars$0.54+11.3%$5.00+828.5%-65.5%$10.47M$59.51M-0.41280Gap UpRNTXRein TherapeuticsN/A$1.66-2.9%N/AN/A$35.97MN/A-0.539News CoverageGap DownPEPGPepGen2.4609 of 5 stars$1.10-2.7%$10.33+839.4%-87.4%$35.96MN/A-0.3730XFORX4 Pharmaceuticals4.3552 of 5 stars$0.20-2.5%$2.83+1,283.5%-84.9%$35.57M$2.56M-2.2880KPTIKaryopharm Therapeutics3.1283 of 5 stars$4.21-1.9%$57.50+1,265.8%-71.8%$35.44M$145.24M-4.13380Short Interest ↑Negative NewsHigh Trading VolumeHOWLWerewolf Therapeutics2.7194 of 5 stars$0.77+8.7%$9.00+1,066.1%-84.4%$34.60M$1.89M-0.5040News CoverageNRXPNRx Pharmaceuticals1.8014 of 5 stars$2.03-1.0%$28.25+1,291.6%-36.5%$34.34MN/A-0.952Short Interest ↑ATRAAtara Biotherapeutics3.9548 of 5 stars$5.85+5.8%$17.75+203.4%-62.7%$34.28M$128.94M-0.23330News CoverageESLAEstrella Immunopharma2.9131 of 5 stars$0.87+0.7%$16.00+1,728.8%-25.8%$31.64MN/A-3.37N/AShort Interest ↓COEPCoeptis Therapeutics0.4396 of 5 stars$9.40flatN/A+51.1%$31.63MN/A-1.622Short Interest ↑News CoverageKZRKezar Life Sciences3.7348 of 5 stars$4.32+9.4%$39.50+814.4%-47.3%$31.56M$7M-0.3360 Related Companies and Tools Related Companies RNTX Competitors PEPG Competitors XFOR Competitors KPTI Competitors HOWL Competitors NRXP Competitors ATRA Competitors ESLA Competitors COEP Competitors KZR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGC) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flora Growth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Flora Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FLGC Stock Free FLGC Stock Alerts